Literature DB >> 20088826

The cathepsin L gene is a direct target of FOXO1 in skeletal muscle.

Yoshihiro Yamazaki1, Yasutomi Kamei, Satoshi Sugita, Fumiko Akaike, Sayaka Kanai, Shinji Miura, Yukio Hirata, Bruce R Troen, Tadahiro Kitamura, Ichizo Nishino, Takayoshi Suganami, Osamu Ezaki, Yoshihiro Ogawa.   

Abstract

FOXO1 (forkhead box O1), a forkhead-type transcription factor whose gene expression is up-regulated in the skeletal muscle during starvation, appears to be a key molecule of energy metabolism and skeletal muscle atrophy. Cathepsin L, a lysosomal proteinase whose expression is also up-regulated in the skeletal muscle during starvation, is induced in transgenic mice overexpressing FOXO1 relative to wild-type littermates. In the present study, we conducted in vivo and in vitro experiments focusing on FOXO1 regulation of Ctsl (cathepsin L gene; CTSL1 in humans) expression in the skeletal muscle. During fasting and refeeding of C57BL/6 mice, Ctsl was regulated in parallel with FOXO1 in the skeletal muscle. Fasting-induced Ctsl expression was attenuated in transgenic mice overexpressing a dominant-negative form of FOXO1 or in skeletal-muscle-specific Foxo1-knockout mice relative to respective wild-type controls. Using C2C12 mouse myoblasts overexpressing a constitutively active form of FOXO1, we showed that FOXO1 induces Ctsl expression. Moreover, we found FOXO1-binding sites in both the mouse Ctsl and human CTSL1 promoters. The luciferase reporter analysis revealed that the mouse Ctsl and human CTSL1 promoters are activated by FOXO1, which is abolished by mutations in the consensus FOXO1-binding sites. Gel mobility-shift and chromatin immunoprecipiation assays showed that FOXO1 is recruited and binds to the Ctsl promoter. The present study provides in vivo and in vitro evidence that Ctsl is a direct target of FOXO1 in the skeletal muscle, thereby suggesting a role for the FOXO1/cathepsin L pathway in fasting-induced skeletal muscle metabolic change and atrophy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20088826     DOI: 10.1042/BJ20091346

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

Review 1.  FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis.

Authors:  Anthony M J Sanchez; Robin B Candau; Henri Bernardi
Journal:  Cell Mol Life Sci       Date:  2014-05       Impact factor: 9.261

2.  Inhibition of forkhead boxO-specific transcription prevents mechanical ventilation-induced diaphragm dysfunction.

Authors:  Ashley J Smuder; Kurt J Sollanek; Kisuk Min; W Bradley Nelson; Scott K Powers
Journal:  Crit Care Med       Date:  2015-05       Impact factor: 7.598

3.  FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle.

Authors:  Songcang Chen; S Armando Villalta; Devendra K Agrawal
Journal:  J Bone Miner Res       Date:  2015-11-09       Impact factor: 6.741

4.  Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.

Authors:  Sarah A Reed; Pooja B Sandesara; Sarah M Senf; Andrew R Judge
Journal:  FASEB J       Date:  2011-11-18       Impact factor: 5.191

Review 5.  Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass.

Authors:  Craig A Goodman; David L Mayhew; Troy A Hornberger
Journal:  Cell Signal       Date:  2011-07-23       Impact factor: 4.315

6.  Low-dose dexamethasone prevents endotoxaemia-induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle.

Authors:  Hannah Crossland; Dumitru Constantin-Teodosiu; Paul L Greenhaff; Sheila M Gardiner
Journal:  J Physiol       Date:  2010-02-22       Impact factor: 5.182

7.  p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle.

Authors:  Sarah M Senf; Pooja B Sandesara; Sarah A Reed; Andrew R Judge
Journal:  Am J Physiol Cell Physiol       Date:  2011-03-09       Impact factor: 4.249

Review 8.  Mechanisms for fiber-type specificity of skeletal muscle atrophy.

Authors:  Yichen Wang; Jeffrey E Pessin
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

Review 9.  Muscle wasting in disease: molecular mechanisms and promising therapies.

Authors:  Shenhav Cohen; James A Nathan; Alfred L Goldberg
Journal:  Nat Rev Drug Discov       Date:  2015-01       Impact factor: 84.694

10.  Serological muscle loss biomarkers: an overview of current concepts and future possibilities.

Authors:  Anders Nedergaard; Morten A Karsdal; Shu Sun; Kim Henriksen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-21       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.